Weingand K, Bloom J, Carakostas M, Hall R, Helfrich M, Latimer K, Levine B, Neptun D, Rebar A, Stitzel K
Procter & Gamble Co., Miami Valley Laboratories, Cincinnati, Ohio 45239.
Toxicol Pathol. 1992;20(3 Pt 2):539-43. doi: 10.1177/0192623392020003217.
Clinical pathology testing in nonclinical toxicity and safety studies is an important part of safety assessment. In recent years, clinical laboratory testing has rapidly expanded and improved. Some government regulatory agencies provide guidelines for clinical pathology testing in nonclinical toxicity and safety studies. To improve these testing guidelines and the resultant safety assessments, the American Association for Clinical Chemistry's Division of Animal Clinical Chemistry and the American Society for Veterinary Clinical Pathology formed a joint committee to provide expert recommendations for clinical pathology testing of laboratory species involved in subchronic and chronic nonclinical toxicity and safety studies. These recommendations include technical recommendations on blood collection techniques and hematology, serum chemistry, and urinalysis tests.
非临床毒性和安全性研究中的临床病理学检测是安全性评估的重要组成部分。近年来,临床实验室检测迅速发展并得到改进。一些政府监管机构为非临床毒性和安全性研究中的临床病理学检测提供了指导原则。为完善这些检测指导原则及由此产生的安全性评估,美国临床化学协会动物临床化学分会和美国兽医临床病理学会成立了一个联合委员会,为参与亚慢性和慢性非临床毒性及安全性研究的实验动物物种的临床病理学检测提供专家建议。这些建议包括关于血液采集技术以及血液学、血清化学和尿液分析检测的技术建议。